Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary goal of this study is to examine the efficacy and feasibility of a mifepristone combined with misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Armenia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

NCT02415894

Other Abortion

COMPLETED

Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))

NCT00969982

Abortion, Induced

COMPLETED NA

Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus

NCT02219100

Abortion, First Trimester

COMPLETED NA

Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan

NCT02235155

Abortion in Second Trimester

COMPLETED

Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)

NCT00957346

Abortion, Induced

TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women who were deemed eligible for the study by the provider gave informed consent. They took 200 mg of mifepristone orally at the study clinic. In 24-44 hours, they returned to the clinic for induction with misoprostol. They were admitted as inpatients at the clinic and took 400 mcg of buccal misoprostol every 3 hours until the fetus and placenta were expelled. If there was no full expulsion after 10 doses of misoprostol, the provider used their discretion to determine the appropriate clinical course of action. After responding to questions about their experience with the procedure, women were discharged from the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abortion in Second Trimester

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant women

Pregnant women of 13-22 weeks gestation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnancy of 13-22 weeks' gestation
* Good general health
* Meeting legal criteria to obtain abortion
* Presenting with closed cervical os and no vaginal bleeding
* Live fetus at time of presentation for service
* Willingness to undergo a surgical completion if necessary
* No contraindications to study procedures, according to provider
* Woman willing and able to consent to procedure, either by reading consent document or by having consent document read to her
* Willingness to follow study procedures

Exclusion Criteria

* Known previous transmural uterine incision
* Known allergy to mifepristone or misoprostol/prostaglandin or other contraindications to the use of mifepristone or misoprostol
* Parity greater than 5
* Any contraindications to vaginal delivery, including placenta previa
* Presentation in active labor (defined as moderate to severe contractions every 10 minutes or less)

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No